These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 21765617)

  • 1. Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant.
    Burnett BP; Bitto A; Altavilla D; Squadrito F; Levy RM; Pillai L
    Mediators Inflamm; 2011; 2011():385780. PubMed ID: 21765617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
    Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Minutoli L; Arcoraci V; Squadrito G; Macrì A; Squadrito F; Altavilla D
    Eur J Pharmacol; 2016 Oct; 789():152-162. PubMed ID: 27450484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages.
    Altavilla D; Squadrito F; Bitto A; Polito F; Burnett BP; Di Stefano V; Minutoli L
    Br J Pharmacol; 2009 Aug; 157(8):1410-8. PubMed ID: 19681869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis.
    Polito F; Bitto A; Irrera N; Squadrito F; Fazzari C; Minutoli L; Altavilla D
    Br J Pharmacol; 2010 Nov; 161(5):1002-11. PubMed ID: 20977452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethyl ester of bilirubin exhibits anti-inflammatory activity through inhibition of secretory phospholipase A2, lipoxygenase and cyclooxygenase.
    Joshi V; Umashankara M; Ramakrishnan C; Nanjaraj Urs AN; Suvilesh KN; Velmurugan D; Rangappa KS; Vishwanath BS
    Arch Biochem Biophys; 2016 May; 598():28-39. PubMed ID: 27060751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.
    Altavilla D; Minutoli L; Polito F; Irrera N; Arena S; Magno C; Rinaldi M; Burnett BP; Squadrito F; Bitto A
    Br J Pharmacol; 2012 Sep; 167(1):95-108. PubMed ID: 22471974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the medical food flavocoxid [corrected] in managing osteoarthritis.
    Gottlieb D; Kuritzky L
    J Pain Palliat Care Pharmacother; 2011; 25(1):49-54. PubMed ID: 21426218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A
    Joshi V; Venkatesha SH; Ramakrishnan C; Nanjaraj Urs AN; Hiremath V; Moudgil KD; Velmurugan D; Vishwanath BS
    Pharmacol Res; 2016 Nov; 113(Pt A):265-275. PubMed ID: 27597642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
    Kong W; Hooper KM; Ganea D
    Brain Behav Immun; 2016 Mar; 53():59-71. PubMed ID: 26541818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrofurandiol stimulation of phospholipase A2, lipoxygenase, and cyclooxygenase gene expression and MCF-7 human breast cancer cell proliferation.
    Markaverich BM; Crowley J; Rodriquez M; Shoulars K; Thompson T
    Environ Health Perspect; 2007 Dec; 115(12):1727-31. PubMed ID: 18087590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavocoxid, a nutraceutical approach to blunt inflammatory conditions.
    Bitto A; Squadrito F; Irrera N; Pizzino G; Pallio G; Mecchio A; Galfo F; Altavilla D
    Mediators Inflamm; 2014; 2014():790851. PubMed ID: 25242871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
    Meshram MA; Bhise UO; Makhal PN; Kaki VR
    Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24R,25-(OH)(2)D(3) mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes.
    Schwartz Z; Sylvia VL; Del Toro F; Hardin RR; Dean DD; Boyan BD
    J Cell Physiol; 2000 Mar; 182(3):390-401. PubMed ID: 10653606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer.
    Aliabadi A; Khanniri E; Mahboubi-Rabbani M; Bayanati M
    Eur J Med Chem; 2023 Dec; 261():115866. PubMed ID: 37862815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
    Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
    Sud'ina GF; Pushkareva MA; Shephard P; Klein T
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.